C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 239/88 (2006.01) A61K 31/517 (2006.01) A61P 25/28 (2006.01) C07D 401/06 (2006.01) C07D 401/14 (2006.01) C07D 403/04 (2006.01) C07D 471/04 (2006.01)
Patent
CA 2743562
The present invention is directed to benzoquinazilinone compounds of formula (I) which are M1 receptor positive allosteric modulators and that are useful in the treatment of diseases in which the M1 receptor is involved, such as Alzheimer's disease, schizophrenia, pain or sleep disorders. The invention is also directed to pharmaceutical compositions comprising the compounds, and to the use of the compounds and compositions in the treatment of diseases mediated by the M1 receptor.
La présente invention se rapporte à des composés de type benzoquinazolinone de formule (I) qui sont des modulateurs allostériques positifs du récepteur M1 et qui sont utiles pour le traitement de maladies dans lequel le récepteur M1 est mis en jeu, tel que la maladie d'Alzheimer, la schizophrénie, la douleur ou les troubles du sommeil. L'invention porte également sur des compositions pharmaceutiques comprenant les composés et sur l'utilisation des composés et des compositions pour le traitement de maladies médiées par le récepteur M1.
Beshore Douglas C.
Di Marco Christina Ng
Greshock Thomas J.
Kuduk Scott D.
Merck Sharp & Dohme Corp.
Norton Rose Or S.e.n.c.r.l. S.r.l./llp
LandOfFree
Aryl methyl benzoquinazolinone m1 receptor positive... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Aryl methyl benzoquinazolinone m1 receptor positive..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Aryl methyl benzoquinazolinone m1 receptor positive... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-2034471